vs

Side-by-side financial comparison of SmartRent, Inc. (SMRT) and Zymeworks Inc. (ZYME). Click either name above to swap in a different company.

SmartRent, Inc. is the larger business by last-quarter revenue ($36.5M vs $27.6M, roughly 1.3× Zymeworks Inc.). SmartRent, Inc. runs the higher net margin — -8.9% vs -71.0%, a 62.1% gap on every dollar of revenue. On growth, Zymeworks Inc. posted the faster year-over-year revenue change (72.6% vs 3.1%). SmartRent, Inc. produced more free cash flow last quarter ($7.7M vs $-31.8M).

Budget Rent a Car System, Inc. is an American car rental company that was founded in 1958 in Los Angeles, California by Morris Mirkin. Budget is a subsidiary of the Avis Budget Group, with its operations headquartered in Parsippany, New Jersey.

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital th...

SMRT vs ZYME — Head-to-Head

Bigger by revenue
SMRT
SMRT
1.3× larger
SMRT
$36.5M
$27.6M
ZYME
Growing faster (revenue YoY)
ZYME
ZYME
+69.5% gap
ZYME
72.6%
3.1%
SMRT
Higher net margin
SMRT
SMRT
62.1% more per $
SMRT
-8.9%
-71.0%
ZYME
More free cash flow
SMRT
SMRT
$39.5M more FCF
SMRT
$7.7M
$-31.8M
ZYME

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
SMRT
SMRT
ZYME
ZYME
Revenue
$36.5M
$27.6M
Net Profit
$-3.2M
$-19.6M
Gross Margin
38.6%
Operating Margin
-10.9%
-80.1%
Net Margin
-8.9%
-71.0%
Revenue YoY
3.1%
72.6%
Net Profit YoY
71.6%
34.3%
EPS (diluted)
$-0.02
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SMRT
SMRT
ZYME
ZYME
Q4 25
$36.5M
Q3 25
$36.2M
$27.6M
Q2 25
$38.3M
$48.7M
Q1 25
$41.3M
$27.1M
Q4 24
$35.4M
$31.0M
Q3 24
$40.5M
$16.0M
Q2 24
$48.5M
$19.2M
Q1 24
$50.5M
$10.0M
Net Profit
SMRT
SMRT
ZYME
ZYME
Q4 25
$-3.2M
Q3 25
$-6.3M
$-19.6M
Q2 25
$-10.9M
$2.3M
Q1 25
$-40.2M
$-22.6M
Q4 24
$-11.4M
$-23.5M
Q3 24
$-9.9M
$-29.9M
Q2 24
$-4.6M
$-37.7M
Q1 24
$-7.7M
$-31.7M
Gross Margin
SMRT
SMRT
ZYME
ZYME
Q4 25
38.6%
Q3 25
26.4%
Q2 25
33.1%
Q1 25
32.8%
Q4 24
28.7%
Q3 24
33.2%
Q2 24
35.7%
Q1 24
38.5%
Operating Margin
SMRT
SMRT
ZYME
ZYME
Q4 25
-10.9%
Q3 25
-19.4%
-80.1%
Q2 25
-30.5%
-1.4%
Q1 25
-99.9%
-94.5%
Q4 24
-36.6%
-71.6%
Q3 24
-29.0%
-213.8%
Q2 24
-14.3%
-222.9%
Q1 24
-20.1%
-376.9%
Net Margin
SMRT
SMRT
ZYME
ZYME
Q4 25
-8.9%
Q3 25
-17.3%
-71.0%
Q2 25
-28.3%
4.8%
Q1 25
-97.2%
-83.5%
Q4 24
-32.3%
-75.8%
Q3 24
-24.5%
-186.6%
Q2 24
-9.5%
-195.8%
Q1 24
-15.2%
-315.6%
EPS (diluted)
SMRT
SMRT
ZYME
ZYME
Q4 25
$-0.02
Q3 25
$-0.03
$-0.26
Q2 25
$-0.06
$0.03
Q1 25
$-0.21
$-0.30
Q4 24
$-0.06
$-0.32
Q3 24
$-0.05
$-0.39
Q2 24
$-0.02
$-0.49
Q1 24
$-0.04
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SMRT
SMRT
ZYME
ZYME
Cash + ST InvestmentsLiquidity on hand
$104.5M
$64.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$232.1M
$320.1M
Total Assets
$320.9M
$397.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SMRT
SMRT
ZYME
ZYME
Q4 25
$104.5M
Q3 25
$100.0M
$64.8M
Q2 25
$105.0M
$98.3M
Q1 25
$125.6M
$76.2M
Q4 24
$142.5M
$66.1M
Q3 24
$163.4M
$122.4M
Q2 24
$187.4M
$71.0M
Q1 24
$204.7M
$114.8M
Stockholders' Equity
SMRT
SMRT
ZYME
ZYME
Q4 25
$232.1M
Q3 25
$234.4M
$320.1M
Q2 25
$238.8M
$334.5M
Q1 25
$250.7M
$325.0M
Q4 24
$289.4M
$338.8M
Q3 24
$305.1M
$367.0M
Q2 24
$329.4M
$406.2M
Q1 24
$333.1M
$438.0M
Total Assets
SMRT
SMRT
ZYME
ZYME
Q4 25
$320.9M
Q3 25
$335.8M
$397.3M
Q2 25
$354.0M
$408.4M
Q1 25
$366.1M
$425.5M
Q4 24
$420.2M
$463.1M
Q3 24
$448.6M
$487.2M
Q2 24
$475.3M
$515.6M
Q1 24
$485.5M
$553.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SMRT
SMRT
ZYME
ZYME
Operating Cash FlowLast quarter
$7.7M
$-31.4M
Free Cash FlowOCF − Capex
$7.7M
$-31.8M
FCF MarginFCF / Revenue
21.0%
-115.2%
Capex IntensityCapex / Revenue
0.0%
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.1M
$-65.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SMRT
SMRT
ZYME
ZYME
Q4 25
$7.7M
Q3 25
$-2.1M
$-31.4M
Q2 25
$-14.9M
$12.1M
Q1 25
$-12.2M
$-3.4M
Q4 24
$-12.0M
$-41.5M
Q3 24
$-3.7M
$-5.9M
Q2 24
$-13.9M
$-25.0M
Q1 24
$-3.3M
$-37.7M
Free Cash Flow
SMRT
SMRT
ZYME
ZYME
Q4 25
$7.7M
Q3 25
$-2.2M
$-31.8M
Q2 25
$-16.2M
$11.6M
Q1 25
$-14.3M
$-3.4M
Q4 24
$-13.3M
$-41.8M
Q3 24
$-3.9M
$-6.8M
Q2 24
$-14.1M
$-25.6M
Q1 24
$-3.4M
$-37.9M
FCF Margin
SMRT
SMRT
ZYME
ZYME
Q4 25
21.0%
Q3 25
-6.1%
-115.2%
Q2 25
-42.3%
23.7%
Q1 25
-34.7%
-12.6%
Q4 24
-37.5%
-134.8%
Q3 24
-9.7%
-42.4%
Q2 24
-29.1%
-133.0%
Q1 24
-6.7%
-377.5%
Capex Intensity
SMRT
SMRT
ZYME
ZYME
Q4 25
0.0%
Q3 25
0.2%
1.5%
Q2 25
3.3%
1.1%
Q1 25
5.3%
0.1%
Q4 24
3.5%
1.0%
Q3 24
0.6%
5.6%
Q2 24
0.5%
3.1%
Q1 24
0.1%
1.8%
Cash Conversion
SMRT
SMRT
ZYME
ZYME
Q4 25
Q3 25
Q2 25
5.21×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SMRT
SMRT

Hosted Services$18.1M50%
Hardware Service$12.5M34%
Smart Operations Solutions$2.6M7%
Access Control$2.0M5%
Other Smart Communities Solutions$1.3M3%

ZYME
ZYME

Segment breakdown not available.

Related Comparisons